In the news
Biorce Receives 44 Million to Develop AI for Clinical Trial Platform
La Vanguardia news article about Biorce.
© 515 Congress
About Biorce
Biorce is an AI healthtech startup, building defensible AI solutions for clinical trial development. Its platform, Aika, is a continuous intelligent layer, from protocol decision to regulatory submission, enabling fewer amendments and a dramatic reduction of cost and time.
Media contact
Lynn Caroline Broeker
PR & Media collaborations
lynn.broeker@biorce.com
